Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients. Azzi L, Focosi D, Dentali F, Baj A, et al. Vaccine 2021 Mar 30. pii: S0264-410X(21)00402.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azzi L, Focosi D, Dentali F, Baj A, et al. Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients. Vaccine 2021 Mar 30. pii: S0264-410X(21)00402.
PMID: 33824042